vixilanciaa wordpress.com
vixilanciaa
FDA clears GSKs Promacta sNDA to treat SAA patients. September 12, 2014. September 12, 2014. The US Food and Drug Administration FDA has given its clearance to supplemental new drug application sNDA for GlaxoSmithKlines GSK Promacta eltrombopag to treat patients with severe aplastic anaemia SAA. SAA is a blood disorder that consists of one marrow failing to produce sufficient red blood cells, white blood cells and platelets. Eltrombopag has been assessed in 43 patients with SAA, who had an in.
OVERVIEW
The site vixilanciaa.wordpress.com presently has a traffic classification of zero (the smaller the more users). We have analyzed ten pages within the web site vixilanciaa.wordpress.com and found two websites referencing vixilanciaa.wordpress.com.
Pages Parsed
10Links to this site
2VIXILANCIAA.WORDPRESS.COM TRAFFIC
The site vixilanciaa.wordpress.com is seeing alternating amounts of traffic all through the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
LINKS TO WEBSITE
Vixilanciaa
Our broad experience, deep expertise, and global infrastructure combine to form the precise solution a life science company needs for compliance with worldwide regulations. As a quality-driven organization, we make a significant investment in learning its clients procedures. There is advantage in centralising all safety data, clinical data, analysis and reportin.
WHAT DOES VIXILANCIAA.WORDPRESS.COM LOOK LIKE?
VIXILANCIAA.WORDPRESS.COM SERVER
We found that the main root page on vixilanciaa.wordpress.com took one thousand six hundred and nine milliseconds to download. I detected a SSL certificate, so we consider this site secure.
Load time
1.609 sec
SSL
SECURE
IP
192.0.78.13
BROWSER IMAGE
SERVER SOFTWARE
We discovered that vixilanciaa.wordpress.com is weilding the nginx os.HTML TITLE
vixilanciaaDESCRIPTION
FDA clears GSKs Promacta sNDA to treat SAA patients. September 12, 2014. September 12, 2014. The US Food and Drug Administration FDA has given its clearance to supplemental new drug application sNDA for GlaxoSmithKlines GSK Promacta eltrombopag to treat patients with severe aplastic anaemia SAA. SAA is a blood disorder that consists of one marrow failing to produce sufficient red blood cells, white blood cells and platelets. Eltrombopag has been assessed in 43 patients with SAA, who had an in.PARSED CONTENT
The site had the following in the homepage, "FDA clears GSKs Promacta sNDA to treat SAA patients." I noticed that the web site stated " The US Food and Drug Administration FDA has given its clearance to supplemental new drug application sNDA for GlaxoSmithKlines GSK Promacta eltrombopag to treat patients with severe aplastic anaemia SAA." They also stated " SAA is a blood disorder that consists of one marrow failing to produce sufficient red blood cells, white blood cells and platelets. Eltrombopag has been assessed in 43 patients with SAA, who had an in."ANALYZE MORE BUSINESSES
CHWZ APORTE NDS
Entretenido y multi 5 que incluye el español. Shiseidou Beauty Solution Kaihatsu Center Kanshuu Project Beauty. Unou Ikusei IQ Breeder Pet to Nakayoku IQ Lesson. MI APORTE 50 EN DS.
Partidos de futbol Vixinho
Martes, 14 de diciembre de 2010. Tras ganar el Colo en la. Arrendada de la u, se impuso 1-0 el conjunto azul, obligando penales. Sábado, 15 de mayo de 2010.